J&J, Bayer Fall as FDA Urges Against Xarelto Expanded Use

J&J, Bayer Fall as FDA Urges Against Xarelto Expanded Use

Bayer HealthCare AG

Bayer and Johnson & Johnson won approval July 1 to market the drug for prevention of blood clots after knee or hip replacement surgery.